A new international consortium to promote Stem Cell-Based Therapy for Huntington's disease
The Stem Cells for Huntington's Disease (SC4HD) is a new international consortium created to promote advanced therapy medicinal product (ATMP) throug1
The Stem Cells for Huntington's Disease (SC4HD) is a new international consortium created to promote advanced therapy medicinal product (ATMP) throug1
Hospital Clínic participated in a study which shows that the implantation of pacemakers and defibrillators has dropped by more than 50% during th1
A study by IDIBAPS-CSIC has identified a mechanism that favors the accumulation of the accumulation of defective mitochondria found in diseases such1
This methodology makes it possible to determine the risk of developing these diseases before symptoms appear in people with REM sleep behavior disord1
An article published in the journal Nature suggests that immunotherapy is effective in patients with HCC of viral origin but does not increase surviv1
A study carried out at Hospital Clínic of Barcelona analysed the outcomes of patients with autoimmune disease and COVID-19 infection who were admitte1
The journal Autophagy has published the 4th edition of an international consensus document on the interpretation, mechanisms, and different multidisc1
Clínic-IDIBAPS researchers have coordinated two review articles on hepatocellular carcinoma (HCC), the most common type of liver cancer, in which the1
The goal of the initiative is to explore the potential of new artificial-intelligence tools to improve current imaging solutions for cancer cases.
A study published in GUT, jointly led by Ki Up Lee of the University of Ulsan, South Korea, and José C. Fernández-Checa, leader of the IDIBAPS-IIBB-C1